| Master regulators and cofactors of human neuronal cell fate specification identified by CRISPR gene activation screens JB Black, SR McCutcheon, S Dube, A Barrera, TS Klann, GA Rice, ... Cell reports 33 (9), 2020 | 58 | 2020 |
| Transcriptional and epigenetic regulators of human CD8+ T cell function identified through orthogonal CRISPR screens SR McCutcheon, AM Swartz, MC Brown, A Barrera, C McRoberts Amador, ... Nature Genetics 55 (12), 2211-2223, 2023 | 31 | 2023 |
| CRISPR‐Cas expands dynamic range of gene expression from T7RNAP promoters SR McCutcheon, KL Chiu, DD Lewis, C Tan Biotechnology Journal 13 (5), 1700167, 2018 | 23 | 2018 |
| Deciphering the impact of genomic variation on function Code of Conduct Committee (alphabetical by last name) Cody Sarah 33 Farrell ... Nature 633 (8028), 47-57, 2024 | 17 | 2024 |
| Epigenome editing technologies for discovery and medicine SR McCutcheon, D Rohm, N Iglesias, CA Gersbach Nature Biotechnology 42 (8), 1199-1217, 2024 | 17 | 2024 |
| Orthogonal CRISPR screens to identify transcriptional and epigenetic regulators of human CD8 T cell function SR McCutcheon, AM Swartz, MC Brown, A Barrera, CMR Amador, ... bioRxiv, 2023 | 4 | 2023 |
| Activation of the imprinted Prader-Willi Syndrome locus by CRISPR-based epigenome editing D Rohm, JB Black, SR McCutcheon, A Barrera, SS Berry, DJ Morone, ... Cell Genomics 5 (2), 2025 | 1 | 2025 |
| CRISPR-based epigenome editing screens in primary human T cells S McCutcheon, CMR Amador, A Barrera, L Humayun, C Gersbach MOLECULAR THERAPY 30 (4), 165-166, 2022 | 1 | 2022 |
